$0.4639
-0.10-18.04%
Últ. Act.: Nov 5, 3:38 PM
Neumora Therapeutics (NMRA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.24 | $-0.31 | $-0.33 | $-0.34 |
| Actual | $-0.23 | $-0.30 | $-0.35 | $-0.35 |
| Surprise | +4.17% | +3.23% | -6.06% | -2.94% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.19 | $-0.17 | $-0.14 | $-0.15 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $-0.23 | $-0.24 | 4.17 % |
| Q1 | May 7, 2026 | $-0.30 | $-0.31 | 3.23 % |
| Q4 | Mar 30, 2026 | $-0.35 | $-0.33 | -6.06 % |
| Q3 | Nov 6, 2025 | $-0.35 | $-0.34 | -2.94 % |